Angela TAMBURINI
PUBBLICAZIONI (degli ultimi cinque anni)
Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate,
cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).Ferrari S,
Meazza C, Palmerini E, Tamburini A, Fagioli F, Cozza R, Ferraresi V, Bisogno G, Mascarin M, Cefalo
G, Manfrini M, Capanna R, Biagini R, Donati D, Picci P. Tumori. 2014 Nov-Dec;100(6):612-9.
Post-relapse survival in patients with Ewing sarcoma.Ferrari S, Luksch R, Hall KS, Fagioli F, Prete A,
Tamburini A, Tienghi A, DiGirolamo S, Paioli A, Abate ME, Podda M, Cammelli S, Eriksson M, Brach
Del Prever A.Pediatr Blood Cancer. 2015 Jun;62(6):994-9.
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing
after standard treatment: a non-randomised phase 2 clinical trial.Grignani G, Palmerini E, Ferraresi
V, D'Ambrosio L, Bertulli R, Asaftei SD, Tamburini A, Pignochino Y, Sangiolo D, Marchesi E, Capozzi
F, Biagini R, Gambarotti M, Fagioli F, Casali PG, Picci P, Ferrari S, Aglietta M; Italian Sarcoma Group.
Lancet Oncol. 2015 Jan;16(1):98-107.
High-dose chemotherapy with autologous stem cell rescue for treatment of retinoblastoma:
report of five cases.Caselli D, Tamburini A, La Torre A, Pollazzi L, Tintori V, Bambi F, Caputo R, Aricò
M. Pediatr Transplant. 2014 Sep;18(6):631-6.
Neuroblastoma with symptomatic epidural compression in the infant: the AIEOP experience.De
Bernardi B, Quaglietta L, Haupt R, Castellano A, Tirtei E, Luksch R, Mastrangelo S, Viscardi E, Indolfi
P, Cellini M, Tamburini A, Erminio G, Gandolfo C, Sorrentino S, Vetrella S, Gigliotti AR. Pediatr
Blood Cancer. 2014 Aug;61(8):1369-75.
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex
and age.Paioli A, Luksch R, Fagioli F, Tamburini A, Cesari M, Palmerini E, Abate ME, Marchesi E,
Balladelli A, Pratelli L, Ferrari S. J Chemother. 2014 Feb;26(1):49-56.
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without
ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS1.Ferrari S, Ruggieri P, Cefalo G, Tamburini A, Capanna R, Fagioli F, Comandone A, Bertulli R,
Bisogno G, Palmerini E, Alberghini M, Parafioriti A, Linari A, Picci P, Bacci G. J Clin Oncol. 2012 Jun
10;30(17):2112-8.
Urinary endothelin-1-like immunoreactivity excretion in Wilms' tumor survivors.Imperiale A,
Olianti C, Bernini G, Tamburini A, Tommasi MS, La Cava G Pediatr Nephrol. 2012 Aug;27(8):1351-9.
Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the
Italian Sarcoma Group Experience (1983-2006).Longhi A, Ferrari S, Tamburini A, Luksch R, Fagioli F,
Bacci G, Ferrari C. Cancer. 2012 Oct 15;118(20):5050-9.
Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with upregulation of hERG1 channels and of the VEGF-A pathway.Fortunato P, Pillozzi S, Tamburini A,
Pollazzi L, Franchi A, La Torre A, Arcangeli A.BMC Cancer. 2010 Sep 22;10:504.
Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the
Italian neuroblastoma registry.Garaventa A, Parodi S, De Bernardi B, Dau D, Manzitti C, Conte M,
Casale F, Viscardi E, Bianchi M, D'Angelo P, Zanazzo GA, Luksch R, Favre C, Tamburini A, Haupt R.
Eur J Cancer. 2009 Nov;45(16):2835-42.
Mol Med. 2002 May;9(5):541-5.
Scarica

pubblicazioni